
New Trial to Investigate Osteoporosis Drug for Type 1 Diabetes
The City of Hope Medical Center has begun a phase 1/2 clinical trial of the osteoporosis medication denosumab to determine if it can improve beta cell health in people with early type 1 diabetes. Amgen’s denosumab is approved as Prolia to treat …